Transcript Sanofi, Q3 2023 Earnings Call, Oct 27, 2023 -October 27 ... - Marketscreener.com
| 278650 Stock | KRW 2,135 50.00 2.29% |
About 61% of KNOTUS CoLtd's investor base is looking to short. The analysis of current outlook of investing in KNOTUS CoLtd suggests that many traders are alarmed regarding KNOTUS CoLtd's prospects. The current market sentiment, together with KNOTUS CoLtd's historical and current headlines, can help investors time the market. In addition, many technical investors use KNOTUS CoLtd stock news signals to limit their universe of possible portfolio assets.
KNOTUS |
Transcript Sanofi, Q3 2023 Earnings Call, Oct 27, 2023 -October 27 ... Marketscreener.com
Read at news.google.com
 |
KNOTUS CoLtd Fundamental Analysis
We analyze KNOTUS CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of KNOTUS CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of KNOTUS CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
KNOTUS CoLtd is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
KNOTUS CoLtd Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with KNOTUS CoLtd stock to make a market-neutral strategy. Peer analysis of KNOTUS CoLtd could also be used in its relative valuation, which is a method of valuing KNOTUS CoLtd by comparing valuation metrics with similar companies.
Peers
KNOTUS CoLtd Related Equities
| 225220 | Genolution | 2.39 | ||||
| 293780 | AptaBio Therapeutics | 0.30 |
Complementary Tools for KNOTUS Stock analysis
When running KNOTUS CoLtd's price analysis, check to measure KNOTUS CoLtd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy KNOTUS CoLtd is operating at the current time. Most of KNOTUS CoLtd's value examination focuses on studying past and present price action to predict the probability of KNOTUS CoLtd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move KNOTUS CoLtd's price. Additionally, you may evaluate how the addition of KNOTUS CoLtd to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |